Earnings Per Share, Basic of Intra-Cellular Therapies, Inc. from 30 Sep 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Intra-Cellular Therapies, Inc. quarterly and annual Earnings Per Share, Basic in USD/shares history and change rate from 30 Sep 2012 to 31 Dec 2024.
  • Intra-Cellular Therapies, Inc. Earnings Per Share, Basic for the quarter ending 31 Dec 2024 was -0.16, a 47% increase year-over-year.
  • Intra-Cellular Therapies, Inc. Earnings Per Share, Basic for the twelve months ending 31 Dec 2024 was -1, a 50% increase year-over-year.
  • Intra-Cellular Therapies, Inc. annual Earnings Per Share, Basic for 2024 was -0.72, a 51% increase from 2023.
  • Intra-Cellular Therapies, Inc. annual Earnings Per Share, Basic for 2023 was -1.46, a 46% increase from 2022.
  • Intra-Cellular Therapies, Inc. annual Earnings Per Share, Basic for 2022 was -2.72, a 22% increase from 2021.
Source SEC data
View on sec.gov
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

Intra-Cellular Therapies, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2024 -1 -0.16 +0.14 +47% 01 Oct 2024 31 Dec 2024 10-K 21 Feb 2025 2024 FY
Q3 2024 -1 -0.25 0 0% 01 Jul 2024 30 Sep 2024 10-K 21 Feb 2025 2024 FY
Q2 2024 -1 -0.16 +0.29 +64% 01 Apr 2024 30 Jun 2024 10-K 21 Feb 2025 2024 FY
Q1 2024 -1 -0.16 +0.3 +65% 01 Jan 2024 31 Mar 2024 10-K 21 Feb 2025 2024 FY
Q4 2023 -1 -0.3 +0.15 +33% 01 Oct 2023 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q3 2023 -2 -0.25 +0.32 +56% 01 Jul 2023 30 Sep 2023 10-K 21 Feb 2025 2024 FY
Q2 2023 -2 -0.45 +0.47 +51% 01 Apr 2023 30 Jun 2023 10-K 21 Feb 2025 2024 FY
Q1 2023 -2 -0.46 +0.32 +41% 01 Jan 2023 31 Mar 2023 10-K 21 Feb 2025 2024 FY
Q4 2022 -3 -0.45 +0.6 +57% 01 Oct 2022 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 -3 -0.57 +0.38 +40% 01 Jul 2022 30 Sep 2022 10-K 22 Feb 2024 2023 FY
Q2 2022 -4 -0.92 -0.07 -8.2% 01 Apr 2022 30 Jun 2022 10-K 22 Feb 2024 2023 FY
Q1 2022 -4 -0.78 -0.13 -20% 01 Jan 2022 31 Mar 2022 10-K 22 Feb 2024 2023 FY
Q4 2021 -4 -1.05 01 Oct 2021 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 -0.95 01 Jul 2021 30 Sep 2021 10-K 01 Mar 2023 2022 FY
Q2 2021 -0.85 01 Apr 2021 30 Jun 2021 10-K 01 Mar 2023 2022 FY
Q1 2021 -0.65 01 Jan 2021 31 Mar 2021 10-K 01 Mar 2023 2022 FY
Q3 2013 -0.42 -0.02 -5% 01 Jul 2013 30 Sep 2013 10-Q 05 Nov 2013 2013 Q3
Q3 2012 -0.4 01 Jul 2012 30 Sep 2012 10-Q 05 Nov 2013 2013 Q3

Intra-Cellular Therapies, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 -0.72 +0.74 +51% 01 Jan 2024 31 Dec 2024 10-K 21 Feb 2025 2024 FY
2023 -1.46 +1.26 +46% 01 Jan 2023 31 Dec 2023 10-K 21 Feb 2025 2024 FY
2022 -2.72 +0.78 +22% 01 Jan 2022 31 Dec 2022 10-K 21 Feb 2025 2024 FY
2021 -3.5 -0.27 -8.4% 01 Jan 2021 31 Dec 2021 10-K 22 Feb 2024 2023 FY
2020 -3.23 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.